Global Monovalent Antivenom Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 94

Published Date: 05 Jul 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Monovalent Antivenom market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Monovalent Antivenom size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Monovalent Antivenom market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Monovalent Antivenom market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Coral Snakes Antivenom
    Sea Snakes Antivenom
    Brown Snake Antivenom
    Others

Market segment by Application can be divided into
    Non-profit Institutions
    Hospitals and Clinic

The key market players for global Monovalent Antivenom market are listed below:
    CSL
    Merck
    BTG
    Pfizer
    Haffkine Bio-Pharmaceutical
    Vins Bioproducts
    Serum Biotech

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Monovalent Antivenom product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Monovalent Antivenom, with price, sales, revenue and global market share of Monovalent Antivenom from 2019 to 2021.
Chapter 3, the Monovalent Antivenom competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Monovalent Antivenom breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Monovalent Antivenom market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Monovalent Antivenom sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Monovalent Antivenom Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Monovalent Antivenom Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Coral Snakes Antivenom
        1.2.3 Sea Snakes Antivenom
        1.2.4 Brown Snake Antivenom
        1.2.5 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Monovalent Antivenom Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Non-profit Institutions
        1.3.3 Hospitals and Clinic
    1.4 Global Monovalent Antivenom Market Size & Forecast
        1.4.1 Global Monovalent Antivenom Sales in Value (2016-2026))
        1.4.2 Global Monovalent Antivenom Sales in Volume (2016-2026)
        1.4.3 Global Monovalent Antivenom Price by Type (2016-2026) & (US$/Unit)
    1.5 Global Monovalent Antivenom Production Capacity Analysis
        1.5.1 Global Monovalent Antivenom Total Production Capacity (2016-2026)
        1.5.2 Global Monovalent Antivenom Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Monovalent Antivenom Market Drivers
        1.6.2 Monovalent Antivenom Market Restraints
        1.6.3 Monovalent Antivenom Trends Analysis

2 Manufacturers Profiles
    2.1 CSL
        2.1.1 CSL Details
        2.1.2 CSL Major Business
        2.1.3 CSL Monovalent Antivenom Product and Services
        2.1.4 CSL Monovalent Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Monovalent Antivenom Product and Services
        2.2.4 Merck Monovalent Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 BTG
        2.3.1 BTG Details
        2.3.2 BTG Major Business
        2.3.3 BTG Monovalent Antivenom Product and Services
        2.3.4 BTG Monovalent Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Pfizer
        2.4.1 Pfizer Details
        2.4.2 Pfizer Major Business
        2.4.3 Pfizer Monovalent Antivenom Product and Services
        2.4.4 Pfizer Monovalent Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Haffkine Bio-Pharmaceutical
        2.5.1 Haffkine Bio-Pharmaceutical Details
        2.5.2 Haffkine Bio-Pharmaceutical Major Business
        2.5.3 Haffkine Bio-Pharmaceutical Monovalent Antivenom Product and Services
        2.5.4 Haffkine Bio-Pharmaceutical Monovalent Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Vins Bioproducts
        2.6.1 Vins Bioproducts Details
        2.6.2 Vins Bioproducts Major Business
        2.6.3 Vins Bioproducts Monovalent Antivenom Product and Services
        2.6.4 Vins Bioproducts Monovalent Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Serum Biotech
        2.7.1 Serum Biotech Details
        2.7.2 Serum Biotech Major Business
        2.7.3 Serum Biotech Monovalent Antivenom Product and Services
        2.7.4 Serum Biotech Monovalent Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Monovalent Antivenom Sales by Manufacturer
    3.1 Global Monovalent Antivenom Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Monovalent Antivenom Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Monovalent Antivenom
    3.4 Market Concentration Rate
        3.4.1 Top 3 Monovalent Antivenom Manufacturer Market Share
        3.4.2 Top 6 Monovalent Antivenom Manufacturer Market Share
    3.5 Global Monovalent Antivenom Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Monovalent Antivenom Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Monovalent Antivenom Market Size by Region
        4.1.1 Global Monovalent Antivenom Sales in Volume by Region (2016-2026)
        4.1.2 Global Monovalent Antivenom Revenue by Region (2016-2026)
    4.2 North America Monovalent Antivenom Revenue (2016-2026)
    4.3 Europe Monovalent Antivenom Revenue (2016-2026)
    4.4 Asia-Pacific Monovalent Antivenom Revenue (2016-2026)
    4.5 South America Monovalent Antivenom Revenue (2016-2026)
    4.6 Middle East and Africa Monovalent Antivenom Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Monovalent Antivenom Sales in Volume by Type (2016-2026)
    5.2 Global Monovalent Antivenom Revenue by Type (2016-2026)
    5.3 Global Monovalent Antivenom Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Monovalent Antivenom Sales in Volume by Application (2016-2026)
    6.2 Global Monovalent Antivenom Revenue by Application (2016-2026)
    6.3 Global Monovalent Antivenom Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Monovalent Antivenom Sales by Type (2016-2026)
    7.2 North America Monovalent Antivenom Sales by Application (2016-2026)
    7.3 North America Monovalent Antivenom Market Size by Country
        7.3.1 North America Monovalent Antivenom Sales in Volume by Country (2016-2026)
        7.3.2 North America Monovalent Antivenom Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Monovalent Antivenom Sales by Type (2016-2026)
    8.2 Europe Monovalent Antivenom Sales by Application (2016-2026)
    8.3 Europe Monovalent Antivenom Market Size by Country
        8.3.1 Europe Monovalent Antivenom Sales in Volume by Country (2016-2026)
        8.3.2 Europe Monovalent Antivenom Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Monovalent Antivenom Sales by Type (2016-2026)
    9.2 Asia-Pacific Monovalent Antivenom Sales by Application (2016-2026)
    9.3 Asia-Pacific Monovalent Antivenom Market Size by Region
        9.3.1 Asia-Pacific Monovalent Antivenom Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Monovalent Antivenom Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Monovalent Antivenom Sales by Type (2016-2026)
    10.2 South America Monovalent Antivenom Sales by Application (2016-2026)
    10.3 South America Monovalent Antivenom Market Size by Country
        10.3.1 South America Monovalent Antivenom Sales in Volume by Country (2016-2026)
        10.3.2 South America Monovalent Antivenom Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Monovalent Antivenom Sales by Type (2016-2026)
    11.2 Middle East & Africa Monovalent Antivenom Sales by Application (2016-2026)
    11.3 Middle East & Africa Monovalent Antivenom Market Size by Country
        11.3.1 Middle East & Africa Monovalent Antivenom Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Monovalent Antivenom Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Monovalent Antivenom Typical Distributors
    12.3 Monovalent Antivenom Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Monovalent Antivenom Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Monovalent Antivenom Revenue by Application, (USD Million), 2021-2026
    Table 3. CSL Basic Information, Manufacturing Base and Competitors
    Table 4. CSL Major Business
    Table 5. CSL Monovalent Antivenom Product and Services
    Table 6. CSL Monovalent Antivenom Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Merck Basic Information, Manufacturing Base and Competitors
    Table 8. Merck Major Business
    Table 9. Merck Monovalent Antivenom Product and Services
    Table 10. Merck Monovalent Antivenom Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. BTG Basic Information, Manufacturing Base and Competitors
    Table 12. BTG Major Business
    Table 13. BTG Monovalent Antivenom Product and Services
    Table 14. BTG Monovalent Antivenom Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 16. Pfizer Major Business
    Table 17. Pfizer Monovalent Antivenom Product and Services
    Table 18. Pfizer Monovalent Antivenom Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Haffkine Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 20. Haffkine Bio-Pharmaceutical Major Business
    Table 21. Haffkine Bio-Pharmaceutical Monovalent Antivenom Product and Services
    Table 22. Haffkine Bio-Pharmaceutical Monovalent Antivenom Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Vins Bioproducts Basic Information, Manufacturing Base and Competitors
    Table 24. Vins Bioproducts Major Business
    Table 25. Vins Bioproducts Monovalent Antivenom Product and Services
    Table 26. Vins Bioproducts Monovalent Antivenom Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Serum Biotech Basic Information, Manufacturing Base and Competitors
    Table 28. Serum Biotech Major Business
    Table 29. Serum Biotech Monovalent Antivenom Product and Services
    Table 30. Serum Biotech Monovalent Antivenom Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Global Monovalent Antivenom Sales by Manufacturer (2019-2021e) & (K Units)
    Table 32. Global Monovalent Antivenom Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 33. Market Position of Manufacturers in Monovalent Antivenom, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 34. Global Monovalent Antivenom Production Capacity by Company, (K Units): 2020 VS 2021
    Table 35. Head Office and Monovalent Antivenom Production Site of Key Manufacturer
    Table 36. Monovalent Antivenom New Entrant and Capacity Expansion Plans
    Table 37. Monovalent Antivenom Mergers & Acquisitions in the Past Five Years
    Table 38. Global Monovalent Antivenom Sales by Region (2016-2021e) & (K Units)
    Table 39. Global Monovalent Antivenom Sales by Region (2021-2026) & (K Units)
    Table 40. Global Monovalent Antivenom Revenue by Region (2016-2021e) & (USD Million)
    Table 41. Global Monovalent Antivenom Revenue by Region (2021-2026) & (USD Million)
    Table 42. Global Monovalent Antivenom Sales by Type (2016-2021e) & (K Units)
    Table 43. Global Monovalent Antivenom Sales by Type (2021-2026) & (K Units)
    Table 44. Global Monovalent Antivenom Revenue by Type (2016-2021e) & (USD Million)
    Table 45. Global Monovalent Antivenom Revenue by Type (2021-2026) & (USD Million)
    Table 46. Global Monovalent Antivenom Price by Type (2016-2021e) & (US$/Unit)
    Table 47. Global Monovalent Antivenom Price by Type (2021-2026) & (US$/Unit)
    Table 48. Global Monovalent Antivenom Sales by Application (2016-2021e) & (K Units)
    Table 49. Global Monovalent Antivenom Sales by Application (2021-2026) & (K Units)
    Table 50. Global Monovalent Antivenom Revenue by Application (2016-2021e) & (USD Million)
    Table 51. Global Monovalent Antivenom Revenue by Application (2021-2026) & (USD Million)
    Table 52. Global Monovalent Antivenom Price by Application (2016-2021e) & (US$/Unit)
    Table 53. Global Monovalent Antivenom Price by Application (2021-2026) & (US$/Unit)
    Table 54. North America Monovalent Antivenom Sales by Country (2016-2021e) & (K Units)
    Table 55. North America Monovalent Antivenom Sales by Country (2021-2026) & (K Units)
    Table 56. North America Monovalent Antivenom Revenue by Country (2016-2021e) & (USD Million)
    Table 57. North America Monovalent Antivenom Revenue by Country (2021-2026) & (USD Million)
    Table 58. North America Monovalent Antivenom Sales by Type (2016-2021e) & (K Units)
    Table 59. North America Monovalent Antivenom Sales by Type (2021-2026) & (K Units)
    Table 60. North America Monovalent Antivenom Sales by Application (2016-2021e) & (K Units)
    Table 61. North America Monovalent Antivenom Sales by Application (2021-2026) & (K Units)
    Table 62. Europe Monovalent Antivenom Sales by Country (2016-2021e) & (K Units)
    Table 63. Europe Monovalent Antivenom Sales by Country (2021-2026) & (K Units)
    Table 64. Europe Monovalent Antivenom Revenue by Country (2016-2021e) & (USD Million)
    Table 65. Europe Monovalent Antivenom Revenue by Country (2021-2026) & (USD Million)
    Table 66. Europe Monovalent Antivenom Sales by Type (2016-2021e) & (K Units)
    Table 67. Europe Monovalent Antivenom Sales by Type (2021-2026) & (K Units)
    Table 68. Europe Monovalent Antivenom Sales by Application (2016-2021e) & (K Units)
    Table 69. Europe Monovalent Antivenom Sales by Application (2021-2026) & (K Units)
    Table 70. Asia-Pacific Monovalent Antivenom Sales by Region (2016-2021e) & (K Units)
    Table 71. Asia-Pacific Monovalent Antivenom Sales by Region (2021-2026) & (K Units)
    Table 72. Asia-Pacific Monovalent Antivenom Revenue by Region (2016-2021e) & (USD Million)
    Table 73. Asia-Pacific Monovalent Antivenom Revenue by Region (2021-2026) & (USD Million)
    Table 74. Asia-Pacific Monovalent Antivenom Sales by Type (2016-2021e) & (K Units)
    Table 75. Asia-Pacific Monovalent Antivenom Sales by Type (2021-2026) & (K Units)
    Table 76. Asia-Pacific Monovalent Antivenom Sales by Application (2016-2021e) & (K Units)
    Table 77. Asia-Pacific Monovalent Antivenom Sales by Application (2021-2026) & (K Units)
    Table 78. South America Monovalent Antivenom Sales by Country (2016-2021e) & (K Units)
    Table 79. South America Monovalent Antivenom Sales by Country (2021-2026) & (K Units)
    Table 80. South America Monovalent Antivenom Revenue by Country (2016-2021e) & (USD Million)
    Table 81. South America Monovalent Antivenom Revenue by Country (2021-2026) & (USD Million)
    Table 82. South America Monovalent Antivenom Sales by Type (2016-2021e) & (K Units)
    Table 83. South America Monovalent Antivenom Sales by Type (2021-2026) & (K Units)
    Table 84. South America Monovalent Antivenom Sales by Application (2016-2021e) & (K Units)
    Table 85. South America Monovalent Antivenom Sales by Application (2021-2026) & (K Units)
    Table 86. Middle East & Africa Monovalent Antivenom Sales by Country (2016-2021e) & (K Units)
    Table 87. Middle East & Africa Monovalent Antivenom Sales by Country (2021-2026) & (K Units)
    Table 88. Middle East & Africa Monovalent Antivenom Revenue by Country (2016-2021e) & (USD Million)
    Table 89. Middle East & Africa Monovalent Antivenom Revenue by Country (2021-2026) & (USD Million)
    Table 90. Middle East & Africa Monovalent Antivenom Sales by Type (2016-2021e) & (K Units)
    Table 91. Middle East & Africa Monovalent Antivenom Sales by Type (2021-2026) & (K Units)
    Table 92. Middle East & Africa Monovalent Antivenom Sales by Application (2016-2021e) & (K Units)
    Table 93. Middle East & Africa Monovalent Antivenom Sales by Application (2021-2026) & (K Units)
    Table 94. Direct Channel Pros & Cons
    Table 95. Indirect Channel Pros & Cons
    Table 96. Monovalent Antivenom Typical Distributors
    Table 97. Monovalent Antivenom Typical Customers
List of Figures
    Figure 1. Monovalent Antivenom Picture
    Figure 2. Global Monovalent Antivenom Sales Market Share by Type in 2020
    Figure 3. Coral Snakes Antivenom
    Figure 4. Sea Snakes Antivenom
    Figure 5. Brown Snake Antivenom
    Figure 6. Others
    Figure 7. Global Monovalent Antivenom Sales Market Share by Application in 2020
    Figure 8. Non-profit Institutions
    Figure 9. Hospitals and Clinic
    Figure 10. Global Monovalent Antivenom Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 11. Global Monovalent Antivenom Market Size and Forecast (2016-2026) & (USD Million)
    Figure 12. Global Monovalent Antivenom Sales (2016-2026) & (K Units)
    Figure 13. Global Monovalent Antivenom Price by Type (2016-2026) & (US$/Unit)
    Figure 14. Global Monovalent Antivenom Production Capacity (2016-2026) & (K Units)
    Figure 15. Global Monovalent Antivenom Production Capacity by Geographic Region: 2020 VS 2021
    Figure 16. Monovalent Antivenom Market Drivers
    Figure 17. Monovalent Antivenom Market Restraints
    Figure 18. Monovalent Antivenom Market Trends
    Figure 19. Global Monovalent Antivenom Sales Market Share by Manufacturer in 2020
    Figure 20. Global Monovalent Antivenom Revenue Market Share by Manufacturer in 2020
    Figure 21. Monovalent Antivenom Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 22. Top 3 Monovalent Antivenom Manufacturer (Revenue) Market Share in 2020
    Figure 23. Top 6 Monovalent Antivenom Manufacturer (Revenue) Market Share in 2020
    Figure 24. Global Monovalent Antivenom Sales Market Share by Region (2016-2026)
    Figure 25. Global Monovalent Antivenom Revenue Market Share by Region (2016-2026)
    Figure 26. North America Monovalent Antivenom Revenue (2016-2026) & (USD Million)
    Figure 27. Europe Monovalent Antivenom Revenue (2016-2026) & (USD Million)
    Figure 28. Asia-Pacific Monovalent Antivenom Revenue (2016-2026) & (USD Million)
    Figure 29. South America Monovalent Antivenom Revenue (2016-2026) & (USD Million)
    Figure 30. Middle East & Africa Monovalent Antivenom Revenue (2016-2026) & (USD Million)
    Figure 31. Global Monovalent Antivenom Sales Market Share by Type (2016-2026)
    Figure 32. Global Monovalent Antivenom Revenue Market Share by Type (2016-2026)
    Figure 33. Global Monovalent Antivenom Price by Type (2016-2026) & (US$/Unit)
    Figure 34. Global Monovalent Antivenom Sales Market Share by Application (2016-2026)
    Figure 35. Global Monovalent Antivenom Revenue Market Share by Application (2016-2026)
    Figure 36. Global Monovalent Antivenom Price by Application (2016-2026) & (US$/Unit)
    Figure 37. North America Monovalent Antivenom Sales Market Share by Type (2016-2026)
    Figure 38. North America Monovalent Antivenom Sales Market Share by Application (2016-2026)
    Figure 39. North America Monovalent Antivenom Sales Market Share by Country (2016-2026)
    Figure 40. North America Monovalent Antivenom Revenue Market Share by Country (2016-2026)
    Figure 41. United States Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 42. Canada Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 43. Mexico Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 44. Europe Monovalent Antivenom Sales Market Share by Type (2016-2026)
    Figure 45. Europe Monovalent Antivenom Sales Market Share by Application (2016-2026)
    Figure 46. Europe Monovalent Antivenom Sales Market Share by Country (2016-2026)
    Figure 47. Europe Monovalent Antivenom Revenue Market Share by Country (2016-2026)
    Figure 48. Germany Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. France Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. United Kingdom Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Russia Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Italy Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Asia-Pacific Monovalent Antivenom Sales Market Share by Region (2016-2026)
    Figure 54. Asia-Pacific Monovalent Antivenom Sales Market Share by Application (2016-2026)
    Figure 55. Asia-Pacific Monovalent Antivenom Sales Market Share by Region (2016-2026)
    Figure 56. Asia-Pacific Monovalent Antivenom Revenue Market Share by Region (2016-2026)
    Figure 57. China Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Japan Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Korea Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. India Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Southeast Asia Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Australia Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. South America Monovalent Antivenom Sales Market Share by Type (2016-2026)
    Figure 64. South America Monovalent Antivenom Sales Market Share by Application (2016-2026)
    Figure 65. South America Monovalent Antivenom Sales Market Share by Country (2016-2026)
    Figure 66. South America Monovalent Antivenom Revenue Market Share by Country (2016-2026)
    Figure 67. Brazil Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Argentina Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Middle East & Africa Monovalent Antivenom Sales Market Share by Type (2016-2026)
    Figure 70. Middle East & Africa Monovalent Antivenom Sales Market Share by Application (2016-2026)
    Figure 71. Middle East & Africa Monovalent Antivenom Sales Market Share by Country (2016-2026)
    Figure 72. Middle East & Africa Monovalent Antivenom Revenue Market Share by Country (2016-2026)
    Figure 73. Turkey Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Egypt Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Saudi Arabia Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. South Africa Monovalent Antivenom Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Sales Channel: Direct Channel vs Indirect Channel
    Figure 78. Methodology
    Figure 79. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Vins Bioproducts
Serum Biotech

Related Reports

Global Monovalent Antivenom Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Monovalent Antivenom Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 18 Jan 2022

date Pharma & Healthcare

The Monovalent Antivenom market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Monovalent Antivenom Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Monovalent Antivenom Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 09 Jan 2023

date Pharma & Healthcare

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

Global Monovalent Antivenom Supply, Demand and Key Producers, 2023-2029

Global Monovalent Antivenom Supply, Demand and Key Producers, 2023-2029

date 03 Mar 2023

date Pharma & Healthcare

The global Monovalent Antivenom market size is expected to reach $ 484.8 million by 2029, rising at a market growth of 3.0% CAGR during the forecast period (2023-2029).

Global Monovalent Antivenom Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Monovalent Antivenom Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Monovalent Antivenom market size was valued at USD 395.1 million in 2023 and is forecast to a readjusted size of USD 484.8 million by 2030 with a CAGR of 3.0% during review period.

Global Monovalent Antivenom Supply, Demand and Key Producers, 2024-2030

Global Monovalent Antivenom Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Pharma & Healthcare

The global Monovalent Antivenom market size is expected to reach $ 484.8 million by 2030, rising at a market growth of 3.0% CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>